Alexion Pharmaceuticals

$163.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$6.14 (+3.90%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ALXN and other stocks, options, and ETFs commission-free!

About ALXN

Alexion Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products.

CEO

Ludwig N. Hantson

Employees

3,837

Headquarters

Boston, Massachusetts

Founded

1992

Market Cap

35.29B

Price-Earnings Ratio

60.22

Dividend Yield

—

Average Volume

2.18M

High Today

$164.57

Low Today

$163.54

Open Price

$163.96

Volume

7.31M

52 Week High

$164.60

52 Week Low

$94.82

Analyst Ratings

19%

of 16 ratings

Buy

19%

Hold

81%

Sell

ALXN Earnings

$0.00

$1.08

$2.16

$3.24

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 5, Pre-Market